LifeStance Health Group, Inc. (LFST) Tops Q1 EPS by 2c, provides guidance

LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q1 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $333 million versus the consensus estimate of $333.33 million.

GUIDANCE:

LifeStance Health Group, Inc. sees FY2025 revenue of $1.40-1.44 billion, versus the consensus of $1.417 billion. And Adjusted EBITDA of $130 million to $150 million.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Worthington Industries (WOR) Misses Q4 EPS by 9c